Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use

Cancer Research

Volumn 62, Issue 1, 2002, Pages 129-134

  Hecht, Stephen S ^a,c   Carmella, Steven G ^a,c   Ye, Ming ^a   Le, Ky Anh ^a   Zimmerman, Cheryl L ^b   Jensen, Joni A ^c   Hatsukami, Dorothy K ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Transdisciplinary Tobacco Use Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CARCINOGEN; GLUCURONIDE;

ADULT; ARTICLE; ENANTIOMER; HALF LIFE TIME; HUMAN; LUNG CARCINOGENESIS; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SMOKELESS TOBACCO; SMOKING CESSATION; STEREOCHEMISTRY; URINALYSIS;

ADMINISTRATION, ORAL; ADULT; GLUCURONATES; HUMANS; MALE; MIDDLE AGED; NITROSAMINES; TOBACCO USE CESSATION; TOBACCO, SMOKELESS;

EID: 0036141389     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines
2. Dose-response relationship between 06-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
3. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines
4. Tobacco-specific N-nitrosamines, and Areca-derived N-nitrosamines, chemistry, biochemistry, carcinogenicity, and relevance to humans
5. Tobacco-specific nitrosamines
6. A comparison of the main-stream smoke chemistry and mutagenicity of a representative sample of the U. S. Cigarette market with two Kentucky reference cigarettes (KIR4F and KIR5F)
7. Five leading U. S. Commercial brands of moist snuff in 1994 - Assessment of carcinogenic N-nitrosamines
8. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
9. Tobacco smoke carcinogens and lung cancer
10. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation
11. Tobacco habits other than smoking: Betel quid and areca nut chewing and some related nitrosamines
12. Oral spit tobacco: Addiction, prevention and treatment
13. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers’ urine
14. Neurotransmission: The autonomic and somatic motor nervous systems
15. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via, β-adrenergic receptor-mediated release of arachidonic acid
16. Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis
17. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine-4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: The impact of a high fiber diet
18. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) enantiomers and metabolites in the A/J mouse
19. Uses and abuses of cotinine as a marker of tobacco smoke exposure
20. Tobacco smoking
21. Comparison of tests used to distinguish smokers from nonsmokers
22. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: Relationship of urinary, biomarkers and oral leukoplakia
23. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition
24. Nicotine metabolism and intake in black and white smokers
25. Nicotine renal excretion rate influences nicotine intake during cigarette smoking
26. Inhibition of cytochrome P450 2A6 increases nicotine’s oral bioavailability and decreases smoking
27. Re: Cigar smoking in men and risk of death from tobacco-related cancers